Free tool
FAERS Monitor: Furoscix
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 209988 or its brand name (Furoscix, Furosemide). Reports on generic versions are filed under their own applications.
Reports
265,818
Serious
219,295
82% of reports
Hospitalization
129,814
Death reported
40,890
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea18,448
- acute kidney injury16,469
- fatigue13,255
- diarrhoea13,197
- death12,375
- nausea11,538
- fall11,004
- off label use10,843
- drug ineffective10,454
- hypotension10,334
- pneumonia10,173
- dizziness9,893
- asthenia9,290
- headache8,713
- pain8,201
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 3,479 |
| 2005 | 3,857 |
| 2006 | 3,623 |
| 2007 | 3,214 |
| 2008 | 3,608 |
| 2009 | 3,997 |
| 2010 | 4,832 |
| 2011 | 6,479 |
| 2012 | 7,274 |
| 2013 | 7,405 |
| 2014 | 10,059 |
| 2015 | 13,254 |
| 2016 | 16,201 |
| 2017 | 16,716 |
| 2018 | 21,192 |
| 2019 | 23,004 |
| 2020 | 20,355 |
| 2021 | 18,734 |
| 2022 | 16,306 |
| 2023 | 16,501 |
| 2024 | 17,514 |
| 2025 | 16,349 |
| 2026 | 11,858 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,788,341 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| acute kidney injurySignal | 16,469 | 9.4 | 9.3 | 111,433 |
| hypotensionSignal | 10,334 | 4.2 | 4.2 | 24,529 |
| fallSignal | 11,004 | 2.7 | 2.6 | 11,304 |
| dyspnoeaSignal | 18,448 | 2.6 | 2.6 | 18,553 |
| pneumoniaSignal | 10,173 | 2.5 | 2.5 | 9,295 |
| asthenia | 9,290 | 2.0 | 1.9 | 4,468 |
| diarrhoea | 13,197 | 1.6 | 1.6 | 3,251 |
| dizziness | 9,893 | 1.6 | 1.6 | 2,120 |
| fatigue | 13,255 | 1.4 | 1.3 | 1,247 |
| nausea | 11,538 | 1.2 | 1.1 | 248 |
| death | 12,375 | 1.1 | 1.1 | 214 |
| headache | 8,713 | 1.1 | 1.1 | 82 |
| pain | 8,201 | 1.1 | 1.0 | 26 |
| off label use | 10,843 | 1.0 | 1.0 | 5 |
| drug ineffective | 10,454 | 0.6 | 0.6 | 2,495 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.